Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-02

Clinical Trial Update: A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil). [Phase 2]

View source ↗

Summary

Phase 2 study assessing the relationship between pharmacokinetic and pharmacodynamic parameters of mycophenolate mofetil (CellCept) in kidney transplant recipie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2015-03-02